Koj puas ua raws li xov xwm Bluebird Bio? Yog tias koj tsis yog, nws yog lub sijhawm kom paub thiab qhib koj cov ntawv ceeb toom rau txhua qhov kev hloov tshiab tshiab txog lub tuam txhab no. Vim nws yog posed mus txog qhov siab tshiab nyob rau txhua lub caij.
Nws cia siab tias cov khoom lag luam ntawm lub tuam txhab no yuav nce siab ntxiv mus rau qhov siab ntxiv raws li pawg neeg tawm tswv yim ntawm Food and Drug Administration (FDA) tau pom zoo ob qho kev sim ntawm lub tuam txhab biotech txoj kev sim tshuaj kho noob.
Yog li koj yuav tau pom cov khoom lag luam ntawm lub tuam txhab nce thiab nce xwb. Rau koj cov ntaub ntawv, ticker 'BLUE' uas koj yuav tau pom ntawm cov ntxaij vab tshaus yog cov tuam txhab tshwj xeeb no. Yog li txawm hais tias tag nrho cov xwm txheej ntawm kev ua lag luam, cov tswv ntawm lub tuam txhab no tau txais qee qhov xav tau kev so.
Qhov tseem ceeb Bluebird Bio News
Qhov no yog Cambridge, Massachusetts-based biotechnology tuam txhab uas yog tsom rau kev tsim kho noob rau kev mob caj ces loj thiab mob qog noj ntshav. Yav dhau los, nws tsuas pom zoo tshuaj los ntawm European Union (EU) yog Betigeglogene autotemcel uas feem ntau mus los ntawm lub npe (Zynteglo).
Kom nco ntsoov, qhov no yog lub ntiaj teb thib ob cov tshuaj kim tshaj plaws hauv ntiaj teb raug nqi $ 1.8 lab. Nrog ntau lub peev xwm lub tuam txhab pom nws cov shares nce tab sis lawv tau poob qis mus txog tam sim no. Nrog kev pom zoo los ntawm ob txoj kev kho mob, nws xav tias yuav rov qab poob kev ntseeg siab hauv nws lub neej yav tom ntej los ntawm cov tub ua lag luam.
Lwm qhov kev ua haujlwm ntawm lub tuam txhab suav nrog LentiGlobin gene therapy rau Sickle cell disease thiab Cerebral Adrenoleukodystrophy. IT kuj tseem ua haujlwm los kho mob Myeloid leukemia, Merkel-cell carcinoma, MAGEA4 cov qog nqaij hlav, thiab Diffuse loj B-cell lymphoma.
Pib nws txoj kev taug raws li Genetix Pharmaceuticals hauv 1992 ib lub tswv yim ntawm MIT kws qhia ntawv cov tswv cuab Irving London thiab Philippe Leboulch, lub koom haum biotechnology no tau pom nws cov nyiaj tau nce mus txog $ 178.29 hauv 2018 thiab tom qab ntawd, lawv tau nyob ntawm qhov kev poob tag nrho.
Tab sis nrog rau cov xov xwm no, cov shares tau nce txog 28.7% mus rau 4.80 rau hnub Monday 14 Lub Rau Hli 2022. Cov khoom lag luam tab tom taug qab rau qhov feem pua nce ntau tshaj plaws hauv yim xyoo dhau los, raws li cov ntaub ntawv los ntawm Dow Jones Market Data. Nws yog qhov tsim nyog kom paub tias cov khoom lag luam poob qis dua 46% xyoo no.
Kev dhia hauv tus nqi yog xav tau los ntawm kev pom zoo ntawm biotech's gene therapies los ntawm Food and Drug Administration. Thaum Lub Rau Hli 9th, Cellular, Tissue, thiab Gene Therapies Advisory Committee ntawm FDA tau pom zoo elivadogene autotmcel lossis Eli-CEL gene therapy.
Txoj kev kho no siv tau rau hauv kev kho mob ntawm tus kab mob uas txuas nrog X chromosome, lub sijhawm ua haujlwm ntawm lub paj hlwb adrenoleukodystrophy. Hnub Friday, tib lub koomhaum tseemfwv tau pom zoo Betibeglogene autotemcel lossis beti-cel, qhov no yog kev kho ib zaug tsim los kho cov neeg mob beta-thalassemia.
Tom qab kev kho mob, yuav tsis muaj qhov xav tau ntawm cov ntshav liab hloov mus rau cov neeg mob cuam tshuam ntawm tus kab mob, uas txwv tsis pub nws yuav tsum tsis tu ncua. FDA yuav tsum txiav txim siab rau beti-cel nyob rau lub Yim Hli 19th thiab hnub rau Eli-CEL yog lub Cuaj Hlis 16 xyoo no.
xaus
Nrog rau cov xov xwm zoo no, cov neeg tau pib nyiam cov khoom lag luam ntawm lub tuam txhab thiab qhov no yog vim li cas cov xov xwm Bluebird Bio tau ua ib puag ncig hauv lub quarter nyiaj txiag thoob plaws lub khw. Txawm hais tias tus nqi mus qhov twg, bluebird yuav tsum tau txais txiaj ntsig zoo los ntawm cov lus pom zoo no.